Advertisement

Strategies to lower the cost of treatment for ATTR-cm

Strategies that may help ease your out-of-pocket costs for treating transthyretin amyloid cardiomyopathy (ATTR-CM).

Updated on October 16, 2025

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare disorder that causes a thickening and stiffening of the heart muscle. This makes it difficult for the heart to pump blood effectively. This reduces heart function, leading to complications like heart failure and arrhythmias, and limiting what a person is capable of doing day to day.

Many people with ATTR-CM require assistance from a caregiver, such as a spouse, adult child, or other loved one. Caregivers may assist with daily tasks like meals, household chores, and getting around. Caregivers are also an important source of emotional support.

Additionally, caregivers are often a part of treatment and treatment decisions. They may communicate with a healthcare team, accompany a loved one to appointments, and manage medications and lifestyle changes at home. They may also be involved in financial aspects of care, like medical bills, insurance coverage, and budgeting for the out-of-pocket costs of treatment.

Treatment and the cost of treatment for ATTR-CM

Your loved one’s ATTR-CM treatment plan will likely involve medications. This can include medications to manage heart failure, arrythmias, and other symptoms. It can also include newer medications that help slow or stop the progression of ATTR-CM.

Some medications used to treat ATTR-CM are only available through specialty pharmacies. Specialty pharmacies fill prescriptions for medications used to treat rare or complex conditions, and also provide additional healthcare support.

Cost is something that needs to be considered when deciding how to treat any medical condition. If the cost of your loved one’s medication is a concern, the following strategies may help.

Talk to your loved one’s healthcare provider

If you have any concerns about treatment—including financial concerns—talk to your loved one’s healthcare provider. The out-of-pocket costs are a significant barrier for many people, and you will not be the first person to bring up this topic at an appointment.

Your loved one’s healthcare provider may be able to recommend strategies to help reduce the cost of treatment or refer you to other healthcare professionals who can help.

Review your loved one’s insurance coverage

Medication cost and coverage can vary between insurance plans. Check your loved one’s insurance plan and compare the prices for different medications. If a medication isn’t covered, ask your healthcare provider if there is a similar medication, and check if that medication is covered.

Review the Summary of Benefits and Coverage (SBC) document. You should be able to access this by logging into the website for your loved one’s insurance provider. Insurance websites also typically have a prescription lookup tool or a “drug formulary,” an index of medications that are covered by that insurance plan. You can also contact your loved one’s insurance provider by phone.

Look for manufacturer discounts and savings

Also visit the website for the medication that you are being prescribed and look for information on savings and support. Many drug manufacturers offer financial assistance programs to help reduce the out-of-pocket costs of medications. A person will need to meet certain eligibility requirements to participate in these programs.

Two types of programs to look for are:

Copay cards

Also known as copay savings programs, copay cards are presented to a pharmacist to apply a discount to a specific medication. Copay cards are usually issued to certain people who have insurance through an employer or insurance they have purchased on their own.

Patient assistance programs (PAPs)

These programs are intended to help cover the cost of medication for people who are uninsured or underinsured. Enrollment and eligibility requirements vary from program to program.

State pharmaceutical assistance programs (SPAPs)

Some states offer financial assistance programs for medications. Eligibility can vary from program to program and medication to medication. You can check for programs in your state by visiting the National Conference of State Legislatures.

Patient advocacy organizations

Another potential source of financial assistance are organizations that advocate for patients and the advancement of ATTR-CM research. Some organizations to look at include:

  • The Assistance Fund (TAF)
  • HealthWell Foundation
  • PAN Foundation (Patient Access Network)

Your loved one’s healthcare provider or a hospital social worker may be able to recommend other resources. Many such organizations also offer resources for patient education and caregiver support.

Compare pharmacy prices

Some health insurance plans also have preferred, in-network pharmacies. This can affect pricing, and the cost of a medication can vary from one pharmacy to another. Check prices between local and online pharmacies.

Article sources open article sources

American Heart Association. Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Accessed October 14, 2025.
Anubhav Jain and Farah Zahra. Transthyretin Amyloid Cardiomyopathy (ATTR-CM). StatPearls. April 27, 2023.
Lucia Ponti, Kristen Hsu, et al. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study. Frontiers in Cardiovascular Medicine. August 28, 2023.
American Heart Association. Help for Heart Failure Caregivers. Accessed October 14, 2025.
Lisa Kitko, Colleen K. McIlvennan, et al. Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association. Circulation, 2020. Vol. 141, No. 22.
Cleveland Clinic. Transthyretin Amyloidosis (ATTR-CM). Accessed October 14, 2025.
Aldostefano Porcari, Gianfranco Sinagra, et al. Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy. European Journal of Internal Medicine. January 5, 2024.
Ashley Gallagher. Pharmacists Can Increase Access to Care for Patients with ATTR-CM. Pharmacy Times. November 27, 2023.
ThienLy Neal. What Are Specialty Pharmacies, and Why Do They Exist? GoodRx. October 26, 2021.
Hongya Chen, Pranav Chandrashekar, et al. Navigating the Complex Web of Prescribing Amyloidosis Therapeutics: A Primer. Journal of the American Heart Association, 2022. Vol. 11, No. 7.
Harlan M. Krumholz, Michelle M. Kittleson, and Kushal T. Kadakia. A Breakthrough With a Burden: Access, Affordability, and the Future of ATTR-CM Therapy. JACC Journals, 2025. Vol. 86, No. 6.
Healthcare.gov. Using your health insurance coverage. Accessed October 14, 2025.
UnitedHealthcare. What’s a Summary of Benefits and Coverage (SBC)? Accessed October 14, 2025.
Healthcare.gov. Summary of Benefits and Coverage. Accessed October 14, 2025.
Medicare.gov. How Do Drug Plans Work? Accessed October 14, 2025.
Lauren Chase. What Are Manufacturer Copay Cards? September 29, 2025.
Lauren Chase. What Are Patient Assistance Programs? April 28, 2022.
Langley Kyle. What’s the Difference Between Manufacturer Coupons and Patient Assistance? RxBenefits. May 25, 2023.
National Conference of State Legislatures. State Pharmaceutical Assistance Programs. Accessed October 14, 2025.
The Assistance Fund. Amyloidosis Financial Assistance Program. Accessed October 14, 2025.
HealthWell Foundation. Cardiomyopathy Medicare Access. Accessed October 14, 2025.
PAN Foundation. Amyloidosis. Accessed October 14, 2025.

Featured Content

article

ATTR cardiomyopathy: Gene silencers and gene stabilizers

A look at two types of disease-modifying therapies used in the treatment of ATTR cardiomyopathy.
article

5 answers about ATTR amyloidosis

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.
article

How to seek support when living with ATTR cardiomyopathy

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.
video

Virtual Journey: ATTR Amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.
article

What are the different types of amyloidosis?

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.